← Oncology Approval Tracker

FDA DECISION ·

Lynparza + bevacizumab

olaparib + bevacizumab · AstraZeneca

FDA approvalNew or expanded indicationOvarian, fallopian tube and primary peritoneal cancers
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First-line maintenance for adults with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer in response to platinum chemotherapy whose tumors were homologous recombination deficiency positive, based on BRCA mutation or genomic instability on an approved test.

LAMPGEN ANALYSIS

Why it matters

Added a biomarker-defined maintenance combination after first-line platinum treatment.

What research teams should watch

Arrange HRD testing early and reconcile planned bevacizumab and oral therapy schedules.

Related study operations checklist

See the staffing responsibilities, timing, and handoff questions for this study setting.

Biomarker-selected first-line maintenance

PRIMARY RECORDS

Sources